Method of preventing diarrhoea
The present invention provides a method for the prevention of the incidence of and/or a reduction in the duration of acute diarrhoea, particularly in travelers, said method comprising orally administering an oligosaccharide composition, in particular a non-digestible oligosaccharide, to a mammal.
1. A method of reducing the incidence of traveler's diarrhoea in a human, comprising orally administering daily to said human an effective amount of a composition comprising a mixture of galactooligosaccharides wherein the mixture of galactooligosaccharides comprises disaccharides Gal (β 1-3)-Glc; Gal (β 1-3)-Gal; Gal (β 1-6)-Gal; Gal (a 1-6)-Gal; trisaccharides Gal (β 1-6)-Gal (β 1-4)-Glc; Gal (β 1-3)-Gal (β 1-4)-Glc; tetrasaccharide Gal (β 1-6)-Gal (β 1-6)-Gal (β 1-4)-Glc and pentasaccharide Gal (β 1-6)-Gal (β 1-6)-Gal (β 1-6)-Gal (β 1-4) Glc for a period of seven days prior to departure and each day during travel away from home, wherein the effective amount of the composition comprises 2.7 g of the galactooligosaccharides in 5.5 g of the composition, and wherein the composition is administered as a single daily dose.
2. A method of reducing the incidence of traveler's diarrhoea in a human, comprising orally administering daily to said human an effective amount of a composition comprising a mixture of galactooligosaccharides wherein the mixture of galactooligosaccharides comprises disaccharides Gal (β1-3)-Glc; Gal (β1-3)-Gal; Gal (β1-6)-Gal; Gal (α 1-6)-Gal; trisaccharides Gal (β 1-6)-(Gal (β 1-4)-Glc; Gal (β 1-3)-Gal (β 1-4)-Glc; tetrasaccharide Gal (β 1-6)-Gal (β 1-4)-Glc and pentasaccharide Gal (β 1-6)-Gal (β 1-6)-Gal (β 1-4) Glc; wherein the effective amount of the composition comprises 2.7 g of the galactooligosaccharides, 1.44 g of lactose and 0.68 g of monosaccharides in 5.5 g of the composition.
3. A method of maintaining bowel movement number, stool consistency and abdominal pain in a human, comprising orally administering daily to said human an effective amount of a composition comprising a mixture of galactooligosaccharides wherein the mixture of galactooligosaccharides comprises disaccharides Gal (β1-3)-Glc; Gal (β1-3)-Gal; Gal (β1-6)-Gal; Gal (α 1-6)-Gal;
trisaccharides Gal (β 1-6)-(Gal (β 1-4)-Glc; Gal (β 1-3)-Gal (β 1-4)-Glc; tetrasaccharide Gal (β1-6)-Gal (β 1-4)-Glc and pentasaccharide Gal (β 1-6)-Gal (β 1-6)-Gal (β 1-4) Glc for a period of seven days prior to departure and each day during travel away from home, wherein the effective amount of the composition comprises 2.7 g of the galactooligosaccharides in 5.5 g of the composition.